(Q33847511)

29 July 2017

1 reference

title

Measles: a disease that has to be eradicated (English)

1 reference

eradication of infectious diseases

29 July 2017

0 references

1 reference

1 reference

Omer MI

1

1 reference

29 July 2017

publication date

1 June 1999

1 reference

Annals of Tropical Paediatrics

29 July 2017

published in

1 reference

29 July 2017

volume

19

1 reference

29 July 2017

issue

2

1 reference

29 July 2017

page(s)

125-134

1 reference

Measles in Equatoria region--south Sudan

29 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1080%2F02724939992446

Overcrowding and intensive exposure as determinants of measles mortality

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02724939992446

Measles mortality and vaccine efficacy in rural West Africa

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02724939992446

The levels of measles antibodies in Nigerian children aged 0-12 months and its relationship with maternal parity

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02724939992446

Measles vaccination in Zaïre--when and how?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02724939992446

Geographic variation in infant loss of maternal measles antibody and in prevalence of rubella antibody

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02724939992446

Additional evidence against measles vaccine administration to infants less than 12 months of age: Altered immune response following active/passive immunization

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02724939992446

Measles revaccination. Persistence and degree of antibody titer by type of immune response

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02724939992446

Booster vaccination with further live attenuated measles vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02724939992446

Measles vaccination and reduction in child mortality: a community study from Guinea-Bissau

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02724939992446

Non-specific beneficial effect of measles immunisation: analysis of mortality studies from developing countries

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02724939992446

Measles outbreaks in the United States, 1987 through 1990.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02724939992446

Priorities in global measles control: report of an outbreak in N'Djamena, Chad

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02724939992446

Measles and pertussis in developing countries with good vaccine coverage

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02724939992446

The elimination of indigenous measles, mumps, and rubella from Finland by a 12-year, two-dose vaccination program

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02724939992446

Extra-alveolar air collections in measles

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02724939992446

Status of measles in The Gambia, 1981.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02724939992446

After the honeymoon in measles control

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02724939992446

Decay of maternally derived measles antibody in a highly vaccinated population in southern Israel

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02724939992446

21 January 2018

Identifiers

DOI

10.1080/02724939992446

1 reference

29 July 2017

1 reference